What stage does Neo Kuma Ventures invest at?

Neo Kuma Ventures invests at the Pre-Seed, Seed, Series A stages.

What is Neo Kuma Ventures's typical check size?

Neo Kuma Ventures typically writes checks of $195K – $1.3M.

What sectors does Neo Kuma Ventures focus on?

Neo Kuma Ventures focuses on Biotech, Digital Health, Healthtech, Mental Health.

Where is Neo Kuma Ventures located?

Neo Kuma Ventures is headquartered in London, GB.

Neo Kuma Ventures

Venture capital

London · Pre-Seed–Series A · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

The fund believes psychedelic compounds represent a paradigm shift in mental health treatment, with FDA breakthrough designations validating their potential to address root causes of mental illness affecting over 350 million patients globally. Investment focuses on the intersection of expanding clinical evidence, regulatory liberalization, and ecosystem development. The firm targets early-stage, science-driven ventures across compounds, clinic operations, digital therapeutics, and care platforms, leveraging expertise in biotech, pharmaceutical development, and policy advocacy to support founders from inception to scale.

Invests inBiotech Digital Health Healthtech Mental Health Europe Global London

Source: firm website, verified Aug 6, 2026.

Stage

Pre-Seed–Series A

Check

$195K – $1.3M

London, GB

Instruments

Equity

Founded

2021

Team · 7 people

from the firm's website & public directories

Clara Burtenshaw· Founder and Investor· Lisbon, Portugalin

A biotech and life sciences investor with over 15 years in venture capital, private equity, operations, and deal execution. Recognized among the most influential women in psychedelics by Business Insider, with education from Oxford University and NYU School of Law.

Sean McLintock· Founder and Advisor· Londonin 𝕏

An entrepreneur and investor with expertise in wealth planning, trade finance, and family office experience. Previously involved with Andela, a high-growth technology company backed by Google Ventures.

Christina Sass· Advisory Board

An executive coach and co-founder and chair of Andela, where she raised over $181M and grew the organization to over 2,000 employees with a $50M run rate within six years. Prior experience includes roles at the MasterCard Foundation and the Clinton Global Initiative.

Dr. Peter Crane· Advisor, Chemical biology

A venture partner with healthcare investment and pharmaceutical expertise, holding a DPhil in Chemical Biology from Oxford University and a master's degree in chemistry from Warwick University.

Dr. Willem Hendrik Gispen· Advisor, Neuropharmacology

A medical biologist and neuroscientist holding distinguished academic positions including Head of the Department of Molecular Neurobiology and Rector Magnificus at Utrecht University, and Director of the Rudolf Magnus Institute for Neuroscience.

Fergus Argyle· Advisor

An experienced investor in public and private companies across credit and equity markets with broad expertise in technology, medical devices, pharmaceuticals, and biologics. Career includes senior roles at Blackrock and boutique investment firms in London and Asia.

Lomax Ward· Advisory Board

Co-founder and general partner at Outsized Ventures focused on human health. Previously a healthcare and life sciences investor at White Cloud and a corporate lawyer at Slaughter and May.

Frequently asked questions

What stage does Neo Kuma Ventures invest at?: Neo Kuma Ventures invests at the Pre-Seed, Seed, Series A stages.
What is Neo Kuma Ventures's typical check size?: Neo Kuma Ventures typically writes checks of $195K – $1.3M.
What sectors does Neo Kuma Ventures focus on?: Neo Kuma Ventures focuses on Biotech, Digital Health, Healthtech, Mental Health.
Where is Neo Kuma Ventures located?: Neo Kuma Ventures is headquartered in London, GB.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Mystic Ventures

Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.

LongeVC

LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.

Foreground Capital

Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.